FULCRUM THERAPEUTICS
3.5700
07-October-24 14:59:58
15 minutes delayed
Stocks
-0.2500
-6.54%
Today's range
3.5500 - 3.7800
ISIN
N/A
Source
NASDAQ
-
Fulcrum Therapeutics Reports Recent Business Highlights and First Quarter 2022 Financial Results
09 May 2022 06:00:02 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 May 2022 07:00:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate at the Upcoming BofA Securities 2022 Healthcare Conference
05 May 2022 07:00:01 By Nasdaq GlobeNewswire
-
02 May 2022 07:00:02 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08 Apr 2022 07:00:00 By Nasdaq GlobeNewswire
-
01 Apr 2022 07:30:00 By Nasdaq GlobeNewswire
-
17 Mar 2022 07:00:02 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 Mar 2022 07:00:00 By Nasdaq GlobeNewswire
-
03 Mar 2022 06:01:00 By Nasdaq GlobeNewswire
-
03 Mar 2022 06:00:01 By Nasdaq GlobeNewswire
-
24 Feb 2022 07:00:02 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 Feb 2022 07:00:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® to Participate in 11th Annual SVB Leerink Global Healthcare Conference
10 Feb 2022 07:00:01 By Nasdaq GlobeNewswire
-
10 Jan 2022 06:00:03 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 Jan 2022 07:00:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® to Present at the 40th Annual J.P. Morgan Healthcare Conference
06 Jan 2022 07:00:01 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Appoints Esther Rajavelu as Chief Financial Officer
04 Jan 2022 07:00:02 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Appoints Sonja L. Banks to its Board of Directors
17 Nov 2021 07:00:01 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Recent Business Highlights and Third Quarter 2021 Financial Results
04 Nov 2021 06:00:02 By Nasdaq GlobeNewswire